Sort
23,748 grants matching “melanoma”
Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy
$1,651,519Thomas Waldmann · Division Of Basic Sciences - Nci · ZIB · FY2014 · CA
Animal Model and Genotyping Core Support Facility
$1,650,597Wendy Du Bois · Division Of Basic Sciences - Nci · ZIC · FY2011 · CA
Imaging mechanisms of metastatic tumor formation in situ
$1,648,061Gaudenz Danuser · Ut Southwestern Medical Center · U54 · FY2025 · CA
DNA Sequencing and FACS Core Facilities
$1,646,795Paul Robbins · Division Of Basic Sciences - Nci · ZIC · FY2013 · CA
Pre-Clinical Development of a Novel Anti-YKL-40 Biologic to Treat Severe Asthma
$1,645,902Geoffrey L Chupp · Yale University · UH3 · FY2017 · HL
Studies of Occupational Cancer (Pesticides)
$1,645,412Michael Alavanja · Division Of Cancer Epidemiology And Genetics · ZIA · FY2011 · CA
Endogenous Nitrite Carcinogenesis in Man
$1,642,348Steven R Tannenbaum · Massachusetts Institute Of Technology · P01 · FY2013 · CA
Enhancing natural killer immunotherapy with first-in-dog trials of inhaled recombinant IL-15 and super-agonist IL-15 in naturally occurring canine cancers
$1,639,796Robert J. Canter · University Of California At Davis · U01 · FY2017 · CA
BIOLOGY OF ONCOGENES AND TUMOR SUPPRESSOR GENES
$1,639,261Massachusetts Institute Of Technology · P01 · FY2004 · CA
Center for Immunotherapeutic Transport Oncophysics
$1,638,268Haifa Shen · Methodist Hospital Research Institute · U54 · FY2019 · CA
Overcoming BRAF-inhibitor Resistance in Melanoma
$1,638,184Antoni Ribas · University Of California Los Angeles · P01 · FY2014 · CA
ER Stress and Mitochondrial Biogenesis in Melanoma
$1,637,236Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2019 · CA
Collaborative Protein Technology Resource - Nano-Scale Protein Analysis Section
$1,636,160Noemi Kedei · Division Of Basic Sciences - Nci · ZIC · FY2024 · CA
STEM CELL-MEDIATED TARGETED THERAPIES FOR METASTATIC MELANOMAS
$1,635,864Brigham & Womens Hospital Inc · · FY2019 · Department of the Army
Novel combined immunotherapeutic strategies for glioma: using pet dogs as a large animal spontaneous model
$1,632,775Grace Elizabeth Pluhar · University Of Minnesota · U01 · FY2017 · CA
Pre-Clinical Development of a Novel Anti-YKL-40 Biologic to Treat Severe Asthma
$1,628,646Geoffrey L Chupp · Yale University · UH3 · FY2018 · HL
Immunohistochemical analysis of tumors
$1,627,902Markku Miettinen · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Integrating NK and DC into Cancer Therapy
$1,625,933Michael T Lotze · University Of Pittsburgh At Pittsburgh · P01 · FY2008 · CA
Prospective validation of a radiomics-based multi-modal predictive model for metastatic non-small cell lung cancer patients treated with PD-1 immunotherapy
$1,625,000Petr Jordan · Onc.Ai, Inc. · R44 · FY2024 · CA
Pre-Clinical Development of a Novel Anti-YKL-40 Biologic to Treat Severe Asthma
$1,623,663Geoffrey L Chupp · Yale University · UH2 · FY2015 · HL
Chemoprevention of arsenic-induced skin cancer
$1,620,244Habibul Ahsan · University Of Chicago · R01 · FY2013 · CA
JHU ICMIC Program
$1,619,134Zaver M Bhujwalla · Johns Hopkins University · P50 · FY2011 · CA
Cancer and Leukemia Group B
$1,615,920Richard L Schilsky · University Of Chicago · U10 · FY2007 · CA
Cytopathology Core
$1,614,548Armando Filie · Division Of Basic Sciences - Nci · ZIC · FY2019 · CA
IL-2IL-15 Cytokine Receptor: Implications for Cancer Therapy and Vaccine Design
$1,614,069Thomas Waldmann · Division Of Clinical Sciences - Nci · ZIA · FY2010 · CA